Skip to main content

Kovack Advisors, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1728321 FT. LAUDERDALE, FL

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$809,713
-$1,670,236 QoQ
Shares Held
6,409
-64.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,162
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Sep 30, 2022
CallValue
$61
CallShares
1
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Kovack Advisors, Inc. holds $33,612,604 across 12 Drug Manufacturers - General names. GILD ranks #8 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GILD
Gilead Sciences, Inc.
This page
6,409 $809,713

All Filings in GILD

Export CSV
33 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $809,713 6,409
2026-03-31 $2,479,949 17,794
2025-12-31 $3,120,173 25,421
2025-09-30 $419,358 3,778
2025-06-30 $419,753 3,786
2025-03-31 $461,085 4,115
2024-12-31 $720,024 7,795
2024-09-30 $764,033 9,113
2024-06-30 $708,672 10,329
2024-03-31 $756,965 10,334
2023-12-31 $850,199 10,495
2023-09-30 $735,161 9,810
2023-06-30 $798,213 10,357
2023-03-31 $894,167 10,777
2022-12-31 $922,200 10,742
2022-09-30 $61 1
2022-09-30 $694,135 11,252
2022-06-30 $693,879 11,226
2022-03-31 $606,627 10,204
2022-03-31 $59 1
2021-12-31 $72 1
2021-12-31 $857,596 11,811
2021-09-30 $928,585 13,294
2021-09-30 $69 1
2021-06-30 $68 1
2021-06-30 $456,335 6,627
2021-03-31 $64 1
2021-03-31 $433,796 6,712
2020-12-31 $826,825 14,192
2020-12-31 $58 1
2020-09-30 $871,832 13,797
2020-06-30 $1,040,613 13,525
2020-03-31 $1,187,263 15,881